Prop 65 andro litigation
This article was originally published in The Tan Sheet
Executive Summary
Weider, MuscleTech, M.D. Labs, SportPharma reach settlements with state of California in ongoing Prop 65 case against androstenedione supplement marketers. Agreements, which include payments for "corrective advertising" programs, penalties and warnings, are similar to consent judgments approved in Oakland state court June 28 (1"The Tan Sheet" June 10, 2002, p. 12). Case management conference with remaining defendants, including Bodyonics, slated for Aug. 2; Judge Ronald Sabraw is considering holding mini-trial on whether andro is anabolic steroid...
You may also be interested in...
Prop 65 Andro Settlements Include “Corrective Advertising” Provision
Settling defendants in California's Prop 65 litigation against androstenedione supplement marketers would pay from $1,341 to $4,546 each to fund "corrective advertising" programs, according to proposed consent judgments filed in Oakland state court
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.